Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA

Cellular Immunology

Volumn 238, Issue 1, 2005, Pages 61-66

  Zhang, Liwang ^a   Zhang, Hongmei ^a   Liu, Wenchao ^a   Wang, Hui ^a   Jia, Jun ^b   Si, Xiaoming ^a   Ren, Jun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Chinese People's Armed Police Forces   (China)

Author keywords

Dendritic cells; Hepatocellular carcinoma; Immunotherapy; Total tumor RNA

Indexed keywords

DENDRITIC CELL VACCINE; RNA;

ARTICLE; CANCER CELL CULTURE; CELL SPECIFICITY; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LIVER CELL CARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VACCINATION;

ANTIGENS, CD; CARCINOMA, HEPATOCELLULAR; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; INTERLEUKIN-12; K562 CELLS; LIVER NEOPLASMS; RNA, NEOPLASM; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 33344468119     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2006.01.003     Document Type: Article

References (18)

1. R. Durr, and W.H. Caselmann Carcinogenesis of primary liver malignancies Langenbecks. Arch. Surg. 385 2000 154 161
2. W.H. Caselmann, H.E. Blum, W.E. Fleig, P.E. Huppert, G. Ramadori, P. Schirmacher, and T. Sauerbruch Guidances of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma, German Society of Digestive and Metabolic Diseases Z. Gastroenterol. 37 1999 353 365
3. E.M. Jaffee, R.H. Hruban, B. Biedrzycki, D. Laheru, K. Schepers, P.R. Sauter, M. Goemann, J. Oleman, L. Grochow, R.C. Donehower, K.D. Lillemoe, S. O'Reilly, R.A. Abrams, D.M. Pardoll, J.L. Cameron, and C.J. Yeo Novel allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immune activation J. Clin. Oncol. 19 2001 145 156
4. M. Schnurr, P. Galambos, C. Scholz, F. Then, M. Dauer, S. Endres, and A. Eigler Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines Cancer Res. 61 2001 6445 6450
5. TL. Whiteside, and C. Odoux Dendritic cell biology and cancer therapy Cancer Immunol. Immunother. 53 2004 240 248
6. L. Zitvogel, J.I. Mayordomo, T. Tjandrawan, A.B. DeLeo, M.R. Clarke, M.T. Lotze, and W.J. Storkus Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J. Exp. Med. 183 1996 87 97
7. J.M. Specht, G. Wang, M.T. Do, J.S. Lam, R.E. Royal, M.E. Reeves, S.A. Rosenberg, and P. Hwu Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary tumor nodules J. Exp. Med. 186 1997 1213 1221
8. P. Paglia, C. Chiodoni, M. Rodolfo, and M.P. Colombo Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo J. Exp. Med. 183 1996 317 322
9. J.I. Mayordomo, T. Zorina, W.J. Storkus, and L. Zitvogel Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity Nat. Med. 1 1995 1297 1302
10. C.M. Celluzzi, J.I. Mayordomo, W.J. Storkus, M.T. Lotze, and L.D. Falo Jr. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity J. Exp. Med. 183 1996 283 287
11. S.E. Strome, S. Voss, R.R.A. Wilcox, T.L. Wakefield, K. Tamada, A.I. Chapoval, J. Lu, J.L. Kasperbauer, D. Padley, R. Vile, D. Gastineau, P.J. Wettstein, and L. Chen Strategies for antigen loading of dendritic cells to enhance the antitumor immune response Cancer Res. 62 2002 1884 1889
12. Y. Kotera, K. Shimizu, and J.J. Mulé Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization Cancer Res. 61 2001 8105 8109
13. J. Wolfers, A. Lozier, G. Raposo, A. Regnault, C. Théry, C. Masurier, C. Flament, S. Pouzieux, F. Faure, T. Tursz, E. Angevin, S. Amigorena, and L. Zitvogel Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming Nat. Med. 7 2001 297 303
14. M.F. Kalady, M.W. Onaitis, S. Emani, Z. Abdul-Wahab, S.K. Pruitt, and D.S. Tyler Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cells J. Gastrointest. Surg. 8 2004 175 181
15. F. Nestle, S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nat. Med. 4 1998 328 332
16. B. Thurner, I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, H. Jonuleit, A. Bender, C. Maczek, D. Schreiner, P. von den Driesch, E.B. Brocker, R.M. Steinman, A. Enk, E. Kampgen, and G. Schuler Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some tumor nodules in advanced stage IV melanoma J. Exp. Med. 190 1999 1669 1678
17. T. Boon, and P. Van der Bruggen Human tumor antigens recognized by T lymphocytes J. Exp. Med. 183 1996 725 729
18. H. Ikeda, B. Lethe, F. Lehmann, N. van Baren, J.F. Baurain, C. de Smet, H. Chambost, M. Vitale, A. Moretta, T. Boon, and P.G. Coulie Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor Immunity 6 1997 199 208